
Honolulu News Today | 2 Min News | The Daily News Now!
Moderna and Merck’s Melanoma Breakthrough | Honolulu News
Moderna and Merck just dropped a game-changing update: an mRNA vaccine for melanoma, the deadliest skin cancer, is showing major promise in late-stage trials. This personalized treatment, paired with Merck’s Keytruda, significantly outperformed Keytruda alone in keeping patients cancer-free. The vaccine works by analyzing a patient’s tumor and creating a custom immune-boosting blueprint to target lingering cancer cells. While results are still being gathered for overall survival, the potential extends beyond melanoma—researchers are exploring its use in lung and bladder cancers. This breakthrough underscores mRNA tech’s leap from pandemic response to revolutionary cancer therapy, offering real hope for patients facing tough diagnoses. Listen in comfort: Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN: advertise@thednn.ai This is an automated, high-level news summary based on public reporting. Report issues to feedback@thednn.ai. View sources & latest updates: https://sources.thednn.ai/fca091bec4bcf444

